GeneDx Holdings (WGS) Revenue Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.49% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 5.54% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 9.66% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 38.82% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 9.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 4.48% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.21% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 11.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.44% |
| Mar 31, 2026 | 17.38% |
| Dec 31, 2025 | 26.50% |
| Sep 30, 2025 | 51.86% |
| Jun 30, 2025 | 45.63% |
| Mar 31, 2025 | 39.56% |
| Dec 31, 2024 | 66.57% |
| Sep 30, 2024 | 44.22% |
| Jun 30, 2024 | 44.77% |
| Mar 31, 2024 | 44.70% |
| Dec 31, 2023 | -6.41% |
| Sep 30, 2023 | -35.96% |
| Jun 30, 2023 | 34.66% |
| Mar 31, 2023 | -20.03% |
| Dec 31, 2022 | 6.14% |
| Sep 30, 2022 | 92.77% |
| Jun 30, 2022 | -23.07% |
| Mar 31, 2022 | -15.98% |
| Dec 31, 2021 | -9.63% |
| Sep 30, 2021 | 11.84% |